Abpro Bio Co., Ltd. (KOSDAQ:195990)

Abpro Bio Statistics

Total Valuation

Abpro Bio has a market cap or net worth of KRW 59.50 billion. The enterprise value is 68.26 billion.

Market Cap	59.50B
Enterprise Value	68.26B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Abpro Bio has 284.69 million shares outstanding. The number of shares has increased by 0.63% in one year.

Current Share Class	284.69M
Shares Outstanding	284.69M
Shares Change (YoY)	+0.63%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	0.35%
Float	264.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.43
PB Ratio	0.95
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.11
EV / Sales	1.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.41

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.32.

Current Ratio	2.36
Quick Ratio	1.33
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-0.99
Interest Coverage	-4.71

Financial Efficiency

Return on equity (ROE) is -66.32% and return on invested capital (ROIC) is -4.05%.

Return on Equity (ROE)	-66.32%
Return on Assets (ROA)	-3.74%
Return on Invested Capital (ROIC)	-4.05%
Return on Capital Employed (ROCE)	-9.78%
Revenue Per Employee	945.18M
Profits Per Employee	-1.39B
Employee Count	44
Asset Turnover	0.34
Inventory Turnover	2.49

Taxes

Income Tax	-407.66M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.86% in the last 52 weeks. The beta is 1.93, so Abpro Bio's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-53.86%
50-Day Moving Average	232.86
200-Day Moving Average	318.74
Relative Strength Index (RSI)	43.03
Average Volume (20 Days)	1,353,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abpro Bio had revenue of KRW 41.59 billion and -61.34 billion in losses. Loss per share was -219.22.

Revenue	41.59B
Gross Profit	1.26B
Operating Income	-7.26B
Pretax Income	-61.75B
Net Income	-61.34B
EBITDA	-5.80B
EBIT	-7.26B
Loss Per Share	-219.22

Balance Sheet

The company has 11.02 billion in cash and 19.78 billion in debt, giving a net cash position of -8.76 billion or -30.76 per share.

Cash & Cash Equivalents	11.02B
Total Debt	19.78B
Net Cash	-8.76B
Net Cash Per Share	-30.76
Equity (Book Value)	62.33B
Book Value Per Share	218.94
Working Capital	20.49B

Cash Flow

In the last 12 months, operating cash flow was -7.62 billion and capital expenditures -12.39 billion, giving a free cash flow of -20.01 billion.

Operating Cash Flow	-7.62B
Capital Expenditures	-12.39B
Free Cash Flow	-20.01B
FCF Per Share	-70.28

Margins

Gross margin is 3.03%, with operating and profit margins of -17.45% and -147.50%.

Gross Margin	3.03%
Operating Margin	-17.45%
Pretax Margin	-148.48%
Profit Margin	-147.50%
EBITDA Margin	-13.94%
EBIT Margin	-17.45%
FCF Margin	n/a

Dividends & Yields

Abpro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.63%
Shareholder Yield	n/a
Earnings Yield	-103.09%
FCF Yield	-33.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 21, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Aug 21, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

Abpro Bio has an Altman Z-Score of 0.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	4